Clinical Study
Early Real-World Experience with CoreValve Evolut PRO and R Systems for Transcatheter Aortic Valve Replacement
Table 1
Baseline characteristics.
| | Evolut PRO (N = 60) | Evolut R (N = 56) | value |
| Age (years) | 84.6 ± 6.3 | 80.4 ± 9.4 | 0.02 | Gender (M/F) | 11/50 | 26/30 | 0.001 | BMI | 27.5 ± 6.8 | 28.8 ± 7.2 | 0.13 | STS score | 7.1 ± 4.0 | 6.5 ± 4.8 | 0.13 | ESRD on HD | 1 | 2 | 0.51 | Hypertension | 54 | 53 | 0.35 | Peripheral artery disease | 7 | 14 | 0.06 | Diabetes mellitus | 18 | 21 | 0.40 | Chronic lung disease | 17 | 23 | 0.15 | Prior PCI | 24 | 23 | 0.90 | Prior CABG | 9 | 16 | 0.08 | Prior MI | 15 | 10 | 0.35 | Prior atrial fibrillation/atrial flutter | 15 | 11 | 0.49 | Prior PM | 13 | 8 | 0.30 | Prior LBBB | 3 | 4 | 0.63 | Prior RBBB | 7 | 7 | 0.89 |
|
|
Values are mean ± standard deviation or n.
|